Geneos Wealth Management Inc. Neuro Metrix, Inc. Transaction History

Geneos Wealth Management Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 May 16, 2022	SELL	$3.42 - $6.37 $17 - $31	-5 Reduced 2.44%	200 $0
Q4 2021 Feb 09, 2022	BUY	$5.02 - $9.82 $1,029 - $2,013	205 New	205 $1,000

320

Ticker NURO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 7,757,230
Market Cap $31.3M
Description
NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to e...

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

Stay updated on Geneos Wealth Management Inc. with notifications on news.